The Saudi-Emirati Global Fertility Network (GFN), one of the region’s fastest-growing fertility and women’s health providers, has finalised the acquisition of a majority stake in HealthPlus Fertility Center in Jeddah. This marks GFN’s second significant deal in Saudi Arabia this year, following its earlier purchase of Bnoon IVF Center in Riyadh. Both clinics will now operate under the Bnoon IVF brand.
Together, these acquisitions represent an investment exceeding 100 million Saudi Riyals (around USD 27 million) and lay the groundwork for GFN’s ambition to establish the largest fertility network across Saudi Arabia and the wider GCC. Previously, both HealthPlus and Bnoon IVF were part of M42’s healthcare portfolio from 2022 to 2024.
With these deals, GFN has doubled its treatment capacity, now performing over 5,000 IVF cycles annually, making it the largest independent provider of assisted reproductive services in the Kingdom. Additionally, a new 3,800-square-metre flagship centre is under construction in northern Riyadh, due to open in December 2025. This facility will offer advanced fertility treatments and reproductive genetics as part of a comprehensive women’s health service.
Majd Abu Zant, Founder and CEO of Global Fertility Network, said: “The expansion in Saudi Arabia is part of GFN’s broader strategy to establish a regional platform of fertility and women’s health centres. Under the Bnoon name, GFN brings together some of the leading Saudi IVF consultants with decades of clinical experience, supported by state-of-the-art IVF laboratories designed to deliver the highest standards in reproductive care.”
The group’s growth is supported by approximately USD 60 million in equity financing from a consortium of institutional investors and family offices from Saudi Arabia and the UAE. Dubai Investments, a publicly listed company on the Dubai Financial Market, holds a 34.3% equity stake in GFN.
“We have identified a strong pipe-line of potential targets for acquisition across the region. New IVF facilities are also planned in Khobar, Abha, and additional cities across the Kingdom. With the support of our investment partners, we will continue to rapidly expand our network while introducing cutting-edge technologies faster, enhancing clinical outcomes, and making fertility care more accessible across the region,” Abu Zant added.
Dr Abdulaziz Muhammad AlShahrani, a leading Saudi Reproductive Endocrinology & Infertility (IVF) Consultant, Founder of Bnoon in Riyadh and Group Medical Director at Bnoon, commented: “We’re seeing a noticeable increase in couples seeking fertility treatment, driven by both primary and secondary infertility. With growing awareness, more individuals are also considering fertility treatments to help balance their families and prevent genetic diseases. Addressing this growing demand requires more than clinical expertise alone. Being part of a larger fertility network like GFN enables us to meet these needs more effectively — giving physicians the freedom to focus on care while benefiting from shared research, innovation, and access to advanced technologies. It’s the kind of ecosystem that drives excellence and expands what’s possible in reproductive medicine.”
Dr Fawaz Adeeb Edris, a renowned Saudi Reproductive Endocrinology & Infertility (IVF) Consultant and Executive Director at Bnoon in Jeddah (formerly HealthPlus Fertility Center), noted the increasing demand for fertility care in the region. “Studies show that fertility rates across the GCC have steadily declined, while infertility affects around 15% of couples — or more — fueling a sharp rise in demand for fertility services.”
He pointed to factors such as delayed parenthood, socioeconomic pressures, obesity, PCOS, and men’s health issues as key contributors. “We are seeing a growing need for accessible, high-quality, and personalised fertility care. By consolidating and expanding leading fertility centres under one unified network, Bnoon aims to broaden access to advanced care and support more couples on their path to parenthood — while integrating the latest medical technologies, AI and data-driven approaches which positions us at the forefront of this rapidly growing healthcare segment. This aligns with Saudi Arabia’s Vision 2030 goals to drive innovation in healthcare and deliver services that meet the evolving needs of our communities.”
About Global Fertility
Global Fertility is creating the leading network of fertility and reproductive genetics centers across the Middle East, with an initial focus on the Kingdom of Saudi Arabia. In 2025, the company acquired two centers in Riyadh and Jeddah, and construction is currently underway for a new flagship facility in North Riyadh as part of its expansion strategy. All centers operate under its unified brand, Bnoon. Global Fertility aims to make Bnoon the largest network in the region and one of the top 10 globally—transforming fertility and women’s health by focusing on research and innovation, deploying leading technology, collaborating with global industry leaders, and putting patients first.
